Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease

View ORCID ProfileMelissa M Higdon, View ORCID ProfileBrian Wahl, View ORCID ProfileCarli B Jones, View ORCID ProfileJoseph G Rosen, View ORCID ProfileShaun A Truelove, View ORCID ProfileAnurima Baidya, View ORCID ProfileAnjalika A Nande, Parisa A ShamaeiZadeh, Karoline K Walter, View ORCID ProfileDaniel R Feikin, View ORCID ProfileMinal K Patel, View ORCID ProfileMaria Deloria Knoll, View ORCID ProfileAlison L Hill
doi: https://doi.org/10.1101/2021.09.17.21263549
Melissa M Higdon
1Department of International Health, Johns Hopkins Bloomberg School of Public Health, 415 N Washington St, Baltimore, MD, USA, 21231
2International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, 415 N Washington St, Baltimore, MD, USA, 21231
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Melissa M Higdon
Brian Wahl
1Department of International Health, Johns Hopkins Bloomberg School of Public Health, 415 N Washington St, Baltimore, MD, USA, 21231
2International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, 415 N Washington St, Baltimore, MD, USA, 21231
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Brian Wahl
Carli B Jones
3Department of Pathology Johns Hopkins University School of Medicine, 600 N Wolfe St, Baltimore, MD, USA, 21287
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carli B Jones
Joseph G Rosen
1Department of International Health, Johns Hopkins Bloomberg School of Public Health, 415 N Washington St, Baltimore, MD, USA, 21231
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joseph G Rosen
Shaun A Truelove
1Department of International Health, Johns Hopkins Bloomberg School of Public Health, 415 N Washington St, Baltimore, MD, USA, 21231
2International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, 415 N Washington St, Baltimore, MD, USA, 21231
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shaun A Truelove
Anurima Baidya
2International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, 415 N Washington St, Baltimore, MD, USA, 21231
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anurima Baidya
Anjalika A Nande
4Institute for Computational Medicine, Johns Hopkins University, 3400 N Charles Street, Baltimore, MD, USA, 21218
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anjalika A Nande
Parisa A ShamaeiZadeh
2International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, 415 N Washington St, Baltimore, MD, USA, 21231
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karoline K Walter
2International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, 415 N Washington St, Baltimore, MD, USA, 21231
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel R Feikin
5Department of Immunization, Vaccines, and Biologicals, World Health Organization, Avenue Appia 20, Geneva, Switzerland, 1211
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel R Feikin
Minal K Patel
5Department of Immunization, Vaccines, and Biologicals, World Health Organization, Avenue Appia 20, Geneva, Switzerland, 1211
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Minal K Patel
Maria Deloria Knoll
1Department of International Health, Johns Hopkins Bloomberg School of Public Health, 415 N Washington St, Baltimore, MD, USA, 21231
2International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, 415 N Washington St, Baltimore, MD, USA, 21231
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Deloria Knoll
Alison L Hill
4Institute for Computational Medicine, Johns Hopkins University, 3400 N Charles Street, Baltimore, MD, USA, 21218
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alison L Hill
  • For correspondence: alhill@jhmi.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Billions of doses of COVID-19 vaccines have been administered globally, dramatically reducing SARS-CoV-2 incidence and severity in some settings. Many studies suggest vaccines provide a high degree of protection against infection and disease, but precise estimates vary and studies differ in design, outcomes measured, dosing regime, location, and circulating virus strains. Here we conduct a systematic review of COVID-19 vaccines through February 2022. We included efficacy data from Phase 3 clinical trials for 15 vaccines undergoing WHO Emergency Use Listing evaluation and real-world effectiveness for 8 vaccines with observational studies meeting inclusion criteria. Vaccine metrics collected include protection against asymptomatic infection, any infection, symptomatic COVID-19, and severe outcomes including hospitalization and death, for partial or complete vaccination, and against variants of concern Alpha, Beta, Gamma, Delta, and Omicron. We additionally review the epidemiological principles behind the design and interpretation of vaccine efficacy and effectiveness studies, including important sources of heterogeneity.

Competing Interest Statement

MMH and MDK have previously received support from a grant from Pfizer Inc to Johns Hopkins University for a non-COVID-19 vaccine. BW provided unpaid technical support to Bharat Biotech related to the clinical development of the BBV152 vaccine candidate. DRF previously served on an independent data monitoring committee for GlaxoSmithKline for a non-COVID-19 vaccine candidate. SAT served as an expert consultant for Milliman, Inc on future COVID-19 trajectories. All other authors declare no competing interests.

Funding Statement

MHH, AB, PS, KW, and MDK received funding to collect the data used in work through a contract from the Center for Epidemic Preparedness Innovations (CEPI) to the International Vaccine Access Center at Johns Hopkins University. CBJ and JGR received funding from the Novel Coronavirus Research Compendium at Johns Hopkins to conduct reviews of COVID-19 vaccine papers for other purposes. ALH and AAN received support from the US National Institutes of Health (NIH DP5OD019851). All other authors received no specific funding support for this work. The study sponsors had no role in the study design, in the collection, analysis, and interpretation of data, in the writing of the report, or in the decision to submit the paper for publication. The views represented in this article do not necessarily reflect the views of the WHO or the NIH.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No IRB was required for this review paper

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • We have updated the review to include studies released through February 3rd, 2022. This increased the number of clinical trials meeting our inclusion criteria from 20 from 22 and for observational studies of vaccine effectiveness from 58 to 107 (plus updates for many previous pre-prints which are now published). The number of unique vaccine products evaluated also increased, from 13 to 15 with clinical trial data, and from 5 to 8 with effectiveness data. We now also have results for the newly emerged Omicron variant. We continue to focus our review on efficacy/effectiveness measures of the primary dose series of COVID-19 vaccines within the first 6 months after administration.

Data Availability

All VE metrics reported in the review are provided in the data supplement (Supplementary Table 1)

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted March 06, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease
Melissa M Higdon, Brian Wahl, Carli B Jones, Joseph G Rosen, Shaun A Truelove, Anurima Baidya, Anjalika A Nande, Parisa A ShamaeiZadeh, Karoline K Walter, Daniel R Feikin, Minal K Patel, Maria Deloria Knoll, Alison L Hill
medRxiv 2021.09.17.21263549; doi: https://doi.org/10.1101/2021.09.17.21263549
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease
Melissa M Higdon, Brian Wahl, Carli B Jones, Joseph G Rosen, Shaun A Truelove, Anurima Baidya, Anjalika A Nande, Parisa A ShamaeiZadeh, Karoline K Walter, Daniel R Feikin, Minal K Patel, Maria Deloria Knoll, Alison L Hill
medRxiv 2021.09.17.21263549; doi: https://doi.org/10.1101/2021.09.17.21263549

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (434)
  • Anesthesia (99)
  • Cardiovascular Medicine (948)
  • Dentistry and Oral Medicine (178)
  • Dermatology (110)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (422)
  • Epidemiology (8987)
  • Forensic Medicine (4)
  • Gastroenterology (420)
  • Genetic and Genomic Medicine (1959)
  • Geriatric Medicine (190)
  • Health Economics (402)
  • Health Informatics (1329)
  • Health Policy (660)
  • Health Systems and Quality Improvement (519)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10809)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1830)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (353)
  • Occupational and Environmental Health (470)
  • Oncology (999)
  • Ophthalmology (298)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (580)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1903)
  • Public and Global Health (4123)
  • Radiology and Imaging (676)
  • Rehabilitation Medicine and Physical Therapy (368)
  • Respiratory Medicine (549)
  • Rheumatology (225)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (177)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (81)